Spatial and temporal diversity in genomic instability processes defines lung cancer evolution
Spatial and temporal dissection of the genomic changes occurring during the evolution of
human non–small cell lung cancer (NSCLC) may help elucidate the basis for its dismal …
human non–small cell lung cancer (NSCLC) may help elucidate the basis for its dismal …
Extensive heterogeneity in somatic mutation and selection in the human bladder
…, B Thomas, V Gnanapragasam, N Williams, DM Rassl… - Science, 2020 - science.org
The extent of somatic mutation and clonal selection in the human bladder remains unknown.
We sequenced 2097 bladder microbiopsies from 20 individuals using targeted (n = 1914 …
We sequenced 2097 bladder microbiopsies from 20 individuals using targeted (n = 1914 …
[HTML][HTML] Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study
…, PL Molyneaux, H Parfrey, DM Rassl… - The Lancet respiratory …, 2017 - thelancet.com
Background Idiopathic pulmonary fibrosis (IPF) is a chronic progressive lung disease with
high mortality, uncertain cause, and few treatment options. Studies have identified a significant …
high mortality, uncertain cause, and few treatment options. Studies have identified a significant …
Suitability of endobronchial ultrasound-guided transbronchial needle aspiration specimens for subtyping and genotyping of non–small cell lung cancer: a multicenter …
…, M Munavvar, BJ Ng, DM Rassl, M Falzon… - American journal of …, 2012 - atsjournals.org
Rationale: The current management of advanced non–small cell lung cancer (NSCLC)
requires differentiation between squamous and nonsquamous subtypes as well as epidermal …
requires differentiation between squamous and nonsquamous subtypes as well as epidermal …
[PDF][PDF] Clearance of senescent macrophages ameliorates tumorigenesis in KRAS-driven lung cancer
…, GJ Doherty, DM Rassl, RC Rintoul, M Signore… - Cancer Cell, 2023 - cell.com
The accumulation of senescent cells in the tumor microenvironment can drive tumorigenesis
in a paracrine manner through the senescence-associated secretory phenotype (SASP). …
in a paracrine manner through the senescence-associated secretory phenotype (SASP). …
ctDNA monitoring using patient-specific sequencing and integration of variant reads
…, JE Abraham, C Caldas, DM Rassl… - Science translational …, 2020 - science.org
Circulating tumor-derived DNA (ctDNA) can be used to monitor cancer dynamics noninvasively.
Detection of ctDNA can be challenging in patients with low-volume or residual disease, …
Detection of ctDNA can be challenging in patients with low-volume or residual disease, …
CD133+ Cancer Stem-like Cells in Small Cell Lung Cancer Are Highly Tumorigenic and Chemoresistant but Sensitive to a Novel Neuropeptide Antagonist
Small cell lung cancer (SCLC) is a highly aggressive malignancy with poor survival rates,
with initial responses nearly invariably followed by rapid recurrence of therapy-resistant …
with initial responses nearly invariably followed by rapid recurrence of therapy-resistant …
[HTML][HTML] British Lung Foundation/United Kingdom Primary Immunodeficiency Network consensus statement on the definition, diagnosis, and management of …
…, J Jacob, AG Nicholson, DM Rassl… - The Journal of Allergy …, 2017 - Elsevier
A proportion of people living with common variable immunodeficiency disorders develop
granulomatous-lymphocytic interstitial lung disease (GLILD). We aimed to develop a …
granulomatous-lymphocytic interstitial lung disease (GLILD). We aimed to develop a …
[HTML][HTML] Lung cancer mortality reduction by LDCT screening: UKLS randomised trial results and international meta-analysis
…, A Nair, RD Page, MKB Parmar, DM Rassl… - The lancet regional …, 2021 - thelancet.com
Background The NLST reported a significant 20% reduction in lung cancer mortality with
three annual low-dose CT (LDCT) screens and the Dutch-Belgian NELSON trial indicates a …
three annual low-dose CT (LDCT) screens and the Dutch-Belgian NELSON trial indicates a …
[HTML][HTML] Biological basis for novel mesothelioma therapies
Mesothelioma is an aggressive cancer that is associated with exposure to asbestos. Although
asbestos is banned in several countries, including the UK, an epidemic of mesothelioma is …
asbestos is banned in several countries, including the UK, an epidemic of mesothelioma is …